📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir. (2023)

First Author: González-Cordón A

Attributed to: Blood borne viruses funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/jac/dkad247

PubMed Identifier: 37539492

Publication URI: http://europepmc.org/abstract/MED/37539492

Type: Journal Article/Review

Volume: 78

Parent Publication: The Journal of antimicrobial chemotherapy

Issue: 9

ISSN: 0305-7453